Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 1/29/21 → 9/18/24 |
Funding
- Celgene: $31,099.00
Expanded Access Protocol (EAP) For Patients Receiving Lisocabtagene Maraleucel That Is Nonconforming For Commercial Release
- Iragavarapu, Chaitanya (PI)
- Hildebrandt, Gerhard (Former PI)